Yep...and considering that amyloid theory is now s
Post# of 1460
Posted On: 11/23/2016 8:11:12 PM
Yep...and considering that amyloid theory is now seemingly not the correct route, AVXL will shine at CTAD. It appears they have a significant head start on those that have been mired in amyloid research. I hope the 52 week data is outstanding! Thanks for the article link.
(0)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼